Glutamine: A key player in human metabolism as revealed by hyperpolarized magnetic resonance.
Level 5 - mechanism / opinion, no new human data
Narrative review of imaging methodology and metabolic pathways without original human clinical trial data.
PubMed 39645348 · doi:10.1016/j.pnmrs.2024.05.003
What was done
This paper reviews the principles of dissolution dynamic nuclear polarization (D-DNP) and its application to studying human metabolism over the past 15 years. It details the cellular and organ-specific roles of glutamine and glutamate, the physics and chemistry of D-DNP hyperpolarization, and the implementation of 13C-labeled glutamine tracking via in vitro and in vivo magnetic resonance imaging (MRI) and magnetic resonance spectroscopy (MRS) in oncology, neurology, and perfusion assessment.
What was found
The abstract reports that D-DNP enhances nuclear polarization by greater than 10,000-fold compared to standard magnetic resonance, enabling time-resolved tracking of structural and enzymatic kinetics at low substrate concentrations. The review describes increased glutamine consumption as a metabolic hallmark of cancer and details its translation to in vivo imaging. No specific empirical patient numbers or clinical outcome statistics are reported in the abstract.
Why it matters
Hyperpolarized 13C magnetic resonance imaging provides a noninvasive method to monitor real-time metabolic fluxes, such as glutaminolysis, which can aid in characterizing tumors and neurological pathologies.
Limits
As a narrative review, it lacks a systematic literature search protocol and does not present original experimental or clinical trial data. The abstract provides no quantitative diagnostic accuracy metrics, patient sample sizes, or comparative clinical outcome measures.